Anti-programmed cell death-1 immune checkpoint therapy (aPD-1) is a cancer immunotherapy that has revolutionized cancer treatment regimens in recent years and is of interest for the treatment of complex keratinocyte carcinoma cases. The gene discussed is PDCD1; the disease is cancer.